GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Opsens Inc (TSX:OPS) » Definitions » EV-to-EBITDA

Opsens (TSX:OPS) EV-to-EBITDA : -34.98 (As of May. 25, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Opsens EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Opsens's enterprise value is C$326.57 Mil. Opsens's EBITDA for the trailing twelve months (TTM) ended in Aug. 2023 was C$-9.34 Mil. Therefore, Opsens's EV-to-EBITDA for today is -34.98.

The historical rank and industry rank for Opsens's EV-to-EBITDA or its related term are showing as below:

TSX:OPS' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1324.65   Med: -16.67   Max: 280.84
Current: -34.98

During the past 13 years, the highest EV-to-EBITDA of Opsens was 280.84. The lowest was -1324.65. And the median was -16.67.

TSX:OPS's EV-to-EBITDA is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 16.205 vs TSX:OPS: -34.98

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-25), Opsens's stock price is C$2.90. Opsens's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2023 was C$-0.110. Therefore, Opsens's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Opsens EV-to-EBITDA Historical Data

The historical data trend for Opsens's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Opsens EV-to-EBITDA Chart

Opsens Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -94.79 -505.93 184.23 -34.87 -23.87

Opsens Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -34.87 -21.36 -17.18 -13.98 -23.87

Competitive Comparison of Opsens's EV-to-EBITDA

For the Medical Instruments & Supplies subindustry, Opsens's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Opsens's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Opsens's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Opsens's EV-to-EBITDA falls into.



Opsens EV-to-EBITDA Calculation

Opsens's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=326.573/-9.335
=-34.98

Opsens's current Enterprise Value is C$326.57 Mil.
Opsens's EBITDA for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-9.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Opsens  (TSX:OPS) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Opsens's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.90/-0.110
=At Loss

Opsens's share price for today is C$2.90.
Opsens's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.110.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Opsens EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Opsens's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Opsens (TSX:OPS) Business Description

Traded in Other Exchanges
N/A
Address
750, Boulevard du Parc-Technologique, Quebec, QC, CAN, G1P 4S3
OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. It operates in two segments that are Medical and Industrial. In Medical segment it supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices. Industrial segment includes developing, manufacturing and installing fibre optic sensing solutions for industrial applications. Majority of its revenue is derived from Medical segment.
Executives
Alan Milinazzo Director
Robin Villeneuve Senior Officer
Fiera Capital Corporation (formerly Fiera Sceptre Inc.) 10% Security Holder

Opsens (TSX:OPS) Headlines

No Headlines